The Cigna Group · 1 week ago
Alternative Investments Analyst - Cigna Investment Management (CIM) - Hybrid
The Cigna Group is a publicly traded global health services company dedicated to improving health and vitality. They are seeking an Alternative Investments Analyst to join their team and help source, evaluate, and execute new investment opportunities while collaborating with experienced investment professionals.
CommercialHealth CareHospitalInsuranceMedical
Responsibilities
Support sourcing, evaluation and execution of limited partnership fund commitments and direct co-investment opportunities to generate attractive risk-adjusted returns
Assist in underwriting by analyzing fund strategies, track records, market dynamics, and risk considerations
Prepare clear, well-supported investment reports and presentations
Contribute to negotiations by reviewing legal documents and coordinating with both internal and external business partners
Monitor existing fund performance and maintain active dialogue with general partners
Research private equity market trends and share insights that inform decision-making
Assist with financial reporting, quarterly updates, and periodic portfolio reviews
Qualification
Required
BA/BS in finance, accounting, or another quantitative field
5+ years of overall business or investment experience
3+ years of relevant experience in credit, private equity, or alternative investments
Strong quantitative and qualitative analytical skills
Strong communication skills (both verbal and written)
Technical proficiency in Excel, Word and PowerPoint
Ability to work collaboratively in a matrixed environment and manage multiple priorities
Strong interpersonal skills, intellectual curiosity, and comfort navigating ambiguity
Ability to accommodate both seasonal and ad-hoc travel (up to 20%)
Preferred
CFA, CPA, MBA, or other advanced financial designation
Company
The Cigna Group
The Cigna Group is a healthcare firm that focuses on providing hospital services and innovative solutions for better health.
Funding
Current Stage
Late StageRecent News
2026-01-06
Company data provided by crunchbase